REFERENCES
- S. Arnolds, and T. Heise. (2007). Inhaled insulin. Best Pract. Res. Clin. Endocrinol. Metab. 21:555–571.
- A. Cripps, M. Riebe, M. Schelze, and R. Woodhouse. (2000). Pharmaceutical transition to non-CFC pressurized metered dose inhalers. Respir. Med. 94:S3–S9.
- (2006). Pipeline Insight: Breakthrough Pain—Fast-acting Players Will Capture Majority Market Share. Datamonitor.
- S. J. Farr, and B. A. Otulana. (2006). Pulmonary delivery of opioids as pain therapeutics. Adv. Drug Del. Rev. 58:1076–1088.
- B. J. Hoeben, D. S. Burgess, J. T. McConville, L. K. Najvar, R. L. Talbert, J. I. Peters, N. P. Wiederhold, J. R. Graybill, R. Bocanegra, K. A. Overhoff, P. Sinswat, K. P. Johnston, and R. O. WilliamsIII. (2006). In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 50:1552–1554.
- T. Lankinen. 1995. Device for more effective pulverization of a powdered inhalation medicamentU.S. Patent No. 5,476,093.
- T. Lankinen. 1997. Device intended for measuring a dose of powdered medicament for inhalationU.S. Patent No. RE35,552.
- T. Lankinen. 2000. Medicament chamber in an inhalation apparatusU.S. Patent No. 6,132,394.
- T. Lankinen. 2003. Method for making a pharmaceutical formulationsU.S. Patent No. 6,616,945 B1.
- T. Lankinen, and H. Salonen. 2006. Method for treating carrier particles and its useU.S. Patent No. US2006/0025326 A1.
- J. T. McConville, K. A. Overhoff, P. Sinswat, J. M. Vaughn, B. L. Frei, D. S. Burgess, R. L. Talbert, J. I. Peters, K. P. Johnston, and R. O. WilliamsIII. (2006). Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model. Pharm. Res. 23:901–911.
- B. J. O'Connor. (2004). The ideal inhaler: Design and characteristics to improve outcomes. Respir. Med. 98:S10–S16.
- S. Sharma, D. White, A. R. Imondi, M. E. Placke, D. M. Vail, and M. G. Kris. (2001). Development of inhalational agents for oncologic use. J. Clin. Oncol. 19:1839–1847.
- I. J. Smith, and M. Parry-Billings. (2003). The inhalers of the future? A review of dry powder devices on the market today. Pulm. Pharmacol. Ther. 16:79–95.
- J. M. Vaughn, J. T. McConville, D. S. Burgess, J. I. Peters, K. P. Johnston, and R. O. WilliamsIII. (2005). Single dose and multiple dose studies of aerosolized itraconazole nanoparticles. Eur. J. Pharm. Biopharm. 63:95–102.
- J. C. Virchow, G. K. Crompton, R. Dal Negro, S. Pedersen, A. Magnan, J. Seidenbergf, and P. J. Barnes. (2008). Importance of inhaler devices in the management of airway disease. Respir. Med. 102:10–19.